Evidence map›Paper›PMID 33237878›Full record

ArticleJournal of medical Internet research2020

Research Output and International Cooperation Among Countries During the COVID-19 Pandemic: Scientometric Analysis.

Nadja Grammes, Dominic Millenaar, Tobias Fehlmann, Fabian Kern, Michael Böhm, Felix Mahfoud, Andreas Keller

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nadja Grammes *Saarland University, Chair for Clinical Bioinformatics, Saarbrücken, Germany.ORCID 0000-0002-4845-2757
Dominic Millenaar *University Hospital of Saarland, Department of Internal Medicine III, Homburg, Germany.ORCID 0000-0001-7061-898X
Tobias FehlmannSaarland University, Chair for Clinical Bioinformatics, Saarbrücken, Germany.ORCID 0000-0003-1967-2918
Fabian KernSaarland University, Chair for Clinical Bioinformatics, Saarbrücken, Germany.ORCID 0000-0002-8223-3750
Michael BöhmUniversity Hospital of Saarland, Department of Internal Medicine III, Homburg, Germany.ORCID 0000-0002-2976-2514
Felix Mahfoud *University Hospital of Saarland, Department of Internal Medicine III, Homburg, Germany.ORCID 0000-0002-4425-549X
Andreas Keller *Saarland University, Chair for Clinical Bioinformatics, Saarbrücken, Germany.ORCID 0000-0002-5361-0895

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has instigated immediate and massive worldwide research efforts. Rapid publication of research data may be desirable but also carries the risk of quality loss.

objectiveThis analysis aimed to correlate the severity of the COVID-19 outbreak with its related scientific output per country.

methodsAll articles related to the COVID-19 pandemic were retrieved from Web of Science and analyzed using the web application SciPE (science performance evaluation), allowing for large data scientometric analyses of the global geographical distribution of scientific output.

resultsA total of 7185 publications, including 2592 articles, 2091 editorial materials, 2528 early access papers, 1479 letters, 633 reviews, and other contributions were extracted. The top 3 countries involved in COVID-19 research were the United States, China, and Italy. The confirmed COVID-19 cases or deaths per region correlated with scientific research output. The United States was most active in terms of collaborative efforts, sharing a significant amount of manuscript authorships with the United Kingdom, China, and Italy. The United States was China's most frequent collaborative partner, followed by the United Kingdom.

conclusionsThe COVID-19 research landscape is rapidly developing and is driven by countries with a generally strong prepandemic research output but is also significantly affected by countries with a high prevalence of COVID-19 cases. Our findings indicate that the United States is leading international collaborative efforts.

Indexed as

COVID-19HumansInternational CooperationPandemicsPublicationsSARS-CoV-2citationcitation analysisCOVID-19literatureresearchSARS-CoV-2scientometric analysis

Identifiers

PMID33237878
PMCPMC7735811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.